Investigating the best treatment options for women with groin hernias
Sex as a Biologic Variable in Groin Hernia
This study is looking at how being a woman affects the treatment options for groin hernias, and it aims to find out if women would be open to participating in a trial comparing surgery to just monitoring their condition, so we can improve care for women with this issue.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11011438 on NIH RePORTER |
What this research studies
This research focuses on understanding how biological sex influences treatment options for groin hernias, particularly in women who often receive less favorable care compared to men. It aims to evaluate the acceptability and feasibility of a clinical trial comparing surgery and watchful waiting for female patients. By addressing barriers to clinical trial participation and ensuring that outcomes are relevant to patients, the research seeks to improve treatment strategies for women with groin hernias. Ultimately, this work will pave the way for a patient-centered clinical trial that could change current treatment guidelines.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with groin hernias who are considering treatment options.
Not a fit: Patients who are male or those who do not have a groin hernia may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for women with groin hernias, potentially reducing unnecessary surgeries.
How similar studies have performed: While there has been limited research specifically addressing watchful waiting in women with groin hernias, similar approaches in other conditions have shown promise in improving patient outcomes.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Ehlers, Anne Pugel — University of Michigan at Ann Arbor
- Study coordinator: Ehlers, Anne Pugel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.